{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:15:16Z","timestamp":1790752516961,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T00:00:00Z","timestamp":1408665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T00:00:00Z","timestamp":1408665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2014.53","type":"journal-article","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T13:19:27Z","timestamp":1408713567000},"page":"e240-e240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Depletion of STAT5 blocks TEL\u2013SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice"],"prefix":"10.1038","volume":"4","author":[{"given":"C","family":"Sprissler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Belenki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Aumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T A","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"H\u00fclsd\u00fcnker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Alexandrovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Brummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Jumaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Duyster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Dierks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,22]]},"reference":[{"key":"BFbcj201453_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/378298a0","volume":"378","author":"M Turner","year":"1995","unstructured":"Turner M, Mee PJ, Costello PS, Williams O, Price AA, Duddy LP et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 1995; 378: 298\u2013302.","journal-title":"Nature"},{"key":"BFbcj201453_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/378303a0","volume":"378","author":"AM Cheng","year":"1995","unstructured":"Cheng AM, Rowley B, Pao W, Hayday A, Bolen JB, Pawson T . Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995; 378: 303\u2013306.","journal-title":"Nature"},{"key":"BFbcj201453_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/intimm\/dxs078","volume":"24","author":"N Ozaki","year":"2012","unstructured":"Ozaki N, Suzuki S, Ishida M, Harada Y, Tanaka K, Sato Y et al. Syk-dependent signaling pathways in neutrophils and macrophages are indispensable in the pathogenesis of anti-collagen antibody-induced arthritis. Int Immunol 2012; 24: 539\u2013550.","journal-title":"Int Immunol"},{"key":"BFbcj201453_CR4","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.4049\/jimmunol.152.10.4758","volume":"152","author":"AC Chan","year":"1994","unstructured":"Chan AC, van Oers NS, Tran A, Turka L, Law CL, Ryan JC et al. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol 1994; 152: 4758\u20134766.","journal-title":"J Immunol"},{"key":"BFbcj201453_CR5","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1182\/blood-2012-09-457887","volume":"121","author":"T Oellerich","year":"2013","unstructured":"Oellerich T, Oellerich MF, Engelke M, Munch S, Mohr S, Nimz M et al. beta2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk\/STAT signaling axis. Blood 2013; 121: 3889\u20133899.","journal-title":"Blood"},{"key":"BFbcj201453_CR6","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1128\/MCB.17.8.4434","volume":"17","author":"S Latour","year":"1997","unstructured":"Latour S, Fournel M, Veillette A . Regulation of T-cell antigen receptor signalling by Syk tyrosine protein kinase. Mol Cell Biol 1997; 17: 4434\u20134441.","journal-title":"Mol Cell Biol"},{"key":"BFbcj201453_CR7","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1084\/jem.181.6.1997","volume":"181","author":"M Thome","year":"1995","unstructured":"Thome M, Duplay P, Guttinger M, Acuto O . Syk and ZAP-70 mediate recruitment of p56lck\/CD4 to the activated T cell receptor\/CD3\/zeta complex. J Exp Med 1995; 181: 1997\u20132006.","journal-title":"J Exp Med"},{"key":"BFbcj201453_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1600-065X.2009.00837.x","volume":"232","author":"Y Kulathu","year":"2009","unstructured":"Kulathu Y, Grothe G, Reth M . Autoinhibition and adapter function of Syk. Immunol Rev 2009; 232: 286\u2013299.","journal-title":"Immunol Rev"},{"key":"BFbcj201453_CR9","first-page":"2595","volume":"13","author":"PS Costello","year":"1996","unstructured":"Costello PS, Turner M, Walters AE, Cunningham CN, Bauer PH, Downward J et al. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 1996; 13: 2595\u20132605.","journal-title":"Oncogene"},{"key":"BFbcj201453_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/1074-7613(95)90081-0","volume":"2","author":"Y Minami","year":"1995","unstructured":"Minami Y, Nakagawa Y, Kawahara A, Miyazaki T, Sada K, Yamamura H et al. Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity 1995; 2: 89\u2013100.","journal-title":"Immunity"},{"key":"BFbcj201453_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1084\/jem.183.4.1407","volume":"183","author":"S Yousefi","year":"1996","unstructured":"Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU . Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 1996; 183: 1407\u20131414.","journal-title":"J Exp Med"},{"key":"BFbcj201453_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/ni.1686","volume":"10","author":"S Hida","year":"2009","unstructured":"Hida S, Yamasaki S, Sakamoto Y, Takamoto M, Obata K, Takai T et al. Fc receptor gamma-chain, a constitutive component of the IL-3 receptor, is required for IL-3-induced IL-4 production in basophils. Nat Immunol 2009; 10: 214\u2013222.","journal-title":"Nat Immunol"},{"key":"BFbcj201453_CR13","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1182\/blood-2009-07-233692","volume":"115","author":"M Buchner","year":"2010","unstructured":"Buchner M, Baer C, Prinz G, Dierks C, Burger M, Zenz T et al. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. Blood 2010; 115: 4497\u20134506.","journal-title":"Blood"},{"key":"BFbcj201453_CR14","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1093\/emboj\/16.21.6414","volume":"16","author":"J Gao","year":"1997","unstructured":"Gao J, Zoller KE, Ginsberg MH, Brugge JS, Shattil SJ . Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. EMBO J 1997; 16: 6414\u20136425.","journal-title":"EMBO J"},{"key":"BFbcj201453_CR15","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1073\/pnas.92.11.5106","volume":"92","author":"JY Bu","year":"1995","unstructured":"Bu JY, Shaw AS, Chan AC . Analysis of the interaction of ZAP-70 and syk protein-tyrosine kinases with the T-cell antigen receptor by plasmon resonance. Proc Natl Acad Sci USA 1995; 92: 5106\u20135110.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201453_CR16","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1073\/pnas.97.4.1713","volume":"97","author":"RJ Cornall","year":"2000","unstructured":"Cornall RJ, Cheng AM, Pawson T, Goodnow CC . Role of Syk in B-cell development and antigen-receptor signaling. Proc Natl Acad Sci USA 2000; 97: 1713\u20131718.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201453_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/oxfordjournals.jbchem.a002970","volume":"130","author":"K Sada","year":"2001","unstructured":"Sada K, Takano T, Yanagi S, Yamamura H . Structure and function of Syk protein-tyrosine kinase. J Biochem 2001; 130: 177\u2013186.","journal-title":"J Biochem"},{"key":"BFbcj201453_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.cell.2007.03.039","volume":"129","author":"S Deindl","year":"2007","unstructured":"Deindl S, Kadlecek TA, Brdicka T, Cao X, Weiss A, Kuriyan J . Structural basis for the inhibition of tyrosine kinase activity of ZAP-70. Cell 2007; 129: 735\u2013746.","journal-title":"Cell"},{"key":"BFbcj201453_CR19","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/emboj.2008.62","volume":"27","author":"Y Kulathu","year":"2008","unstructured":"Kulathu Y, Hobeika E, Turchinovich G, Reth M . The kinase Syk as an adaptor controlling sustained calcium signalling and B-cell development. EMBO J 2008; 27: 1333\u20131344.","journal-title":"EMBO J"},{"key":"BFbcj201453_CR20","doi-asserted-by":"publisher","first-page":"32662","DOI":"10.1074\/jbc.274.46.32662","volume":"274","author":"LO Beitz","year":"1999","unstructured":"Beitz LO, Fruman DA, Kurosaki T, Cantley LC, Scharenberg AM . SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling. J Biol Chem 1999; 274: 32662\u201332666.","journal-title":"J Biol Chem"},{"key":"BFbcj201453_CR21","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1074\/jbc.M407805200","volume":"280","author":"KD Moon","year":"2005","unstructured":"Moon KD, Post CB, Durden DL, Zhou Q, De P, Harrison ML et al. Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase. J Biol Chem 2005; 280: 1543\u20131551.","journal-title":"J Biol Chem"},{"key":"BFbcj201453_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1084\/jem.188.4.791","volume":"188","author":"J Wienands","year":"1998","unstructured":"Wienands J, Schweikert J, Wollscheid B, Jumaa H, Nielsen PJ, Reth M . SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J Exp Med 1998; 188: 791\u2013795.","journal-title":"J Exp Med"},{"key":"BFbcj201453_CR23","doi-asserted-by":"publisher","first-page":"6461","DOI":"10.1093\/emboj\/cdf658","volume":"21","author":"CW Chiu","year":"2002","unstructured":"Chiu CW, Dalton M, Ishiai M, Kurosaki T, Chan AC . BLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteins. Embo J 2002; 21: 6461\u20136472.","journal-title":"Embo J"},{"key":"BFbcj201453_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1074-7613(00)80273-3","volume":"5","author":"M Deckert","year":"1996","unstructured":"Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A . Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 1996; 5: 591\u2013604.","journal-title":"Immunity"},{"key":"BFbcj201453_CR25","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1128\/MCB.16.4.1305","volume":"16","author":"CL Law","year":"1996","unstructured":"Law CL, Chandran KA, Sidorenko SP, Clark EA . Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol Cell Biol 1996; 16: 1305\u20131315.","journal-title":"Mol Cell Biol"},{"key":"BFbcj201453_CR26","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.4049\/jimmunol.176.10.5715","volume":"176","author":"M Gururajan","year":"2006","unstructured":"Gururajan M, Jennings CD, Bondada S . Cutting edge: constitutive B cell receptor signaling is critical for basal growth of B lymphoma. J Immunol 2006; 176: 5715\u20135719.","journal-title":"J Immunol"},{"key":"BFbcj201453_CR27","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1182\/blood-2007-07-100115","volume":"111","author":"L Chen","year":"2008","unstructured":"Chen L, Monti S, Juszczynski P, Daley J, Chen W, Witzig TE et al. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 2008; 111: 2230\u20132237.","journal-title":"Blood"},{"key":"BFbcj201453_CR28","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cellsig.2009.03.007","volume":"21","author":"L Carsetti","year":"2009","unstructured":"Carsetti L, Laurenti L, Gobessi S, Longo PG, Leone G, Efremov DG . Phosphorylation of the activation loop tyrosines is required for sustained Syk signaling and growth factor-independent B-cell proliferation. Cell Signal 2009; 21: 1187\u20131194.","journal-title":"Cell Signal"},{"key":"BFbcj201453_CR29","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1158\/0008-5472.CAN-08-4252","volume":"69","author":"M Buchner","year":"2009","unstructured":"Buchner M, Fuchs S, Prinz G, Pfeifer D, Bartholome K, Burger M et al. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. Cancer Res 2009; 69: 5424\u20135432.","journal-title":"Cancer Res"},{"key":"BFbcj201453_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature11309","volume":"489","author":"M Duhren-von Minden","year":"2012","unstructured":"Duhren-von Minden M, Ubelhart R, Schneider D, Wossning T, Bach MP, Buchner M et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 2012; 489: 309\u2013312.","journal-title":"Nature"},{"key":"BFbcj201453_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ccr.2009.08.018","volume":"16","author":"CK Hahn","year":"2009","unstructured":"Hahn CK, Berchuck JE, Ross KN, Kakoza RM, Clauser K, Schinzel AC et al. Proteomic and genetic approaches identify Syk as an AML target. Cancer Cell 2009; 16: 281\u2013294.","journal-title":"Cancer Cell"},{"key":"BFbcj201453_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.leu.2404045","volume":"20","author":"B Streubel","year":"2006","unstructured":"Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A . Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006; 20: 313\u2013318.","journal-title":"Leukemia"},{"key":"BFbcj201453_CR33","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.1158\/0008-5472.CAN-08-3719","volume":"70","author":"C Dierks","year":"2010","unstructured":"Dierks C, Adrian F, Fisch P, Ma H, Maurer H, Herchenbach D et al. The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease. Cancer Res 2010; 70: 6193\u20136204.","journal-title":"Cancer Res"},{"key":"BFbcj201453_CR34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1084\/jem.20092042","volume":"207","author":"K Pechloff","year":"2010","unstructured":"Pechloff K, Holch J, Ferch U, Schweneker M, Brunner K, Kremer M et al. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J Exp Med 2010; 207: 1031\u20131044.","journal-title":"J Exp Med"},{"key":"BFbcj201453_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1046\/j.1365-2141.1999.01607.x","volume":"106","author":"Y Kuno","year":"1999","unstructured":"Kuno Y, Abe A, Emi N, Iida M, Yamamori T, Tanimoto M et al. An atypical myelodysplastic syndrome with t(9;12)(q22;p12) and TEL gene rearrangement. Br J Haematol 1999; 106: 570\u2013571.","journal-title":"Br J Haematol"},{"key":"BFbcj201453_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/sj.leu.2403266","volume":"18","author":"T Kanie","year":"2004","unstructured":"Kanie T, Abe A, Matsuda T, Kuno Y, Towatari M, Yamamoto T et al. TEL-Syk fusion constitutively activates PI3-K\/Akt, MAPK and JAK2-independent STAT5 signal pathways. Leukemia 2004; 18: 548\u2013555.","journal-title":"Leukemia"},{"key":"BFbcj201453_CR37","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1182\/blood.V97.4.1050","volume":"97","author":"Y Kuno","year":"2001","unstructured":"Kuno Y, Abe A, Emi N, Iida M, Yokozawa T, Towatari M et al. Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12). Blood 2001; 97: 1050\u20131055.","journal-title":"Blood"},{"key":"BFbcj201453_CR38","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1084\/jem.20060967","volume":"203","author":"T Wossning","year":"2006","unstructured":"Wossning T, Herzog S, Kohler F, Meixlsperger S, Kulathu Y, Mittler G et al. Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells. J Exp Med 2006; 203: 2829\u20132840.","journal-title":"J Exp Med"},{"key":"BFbcj201453_CR39","doi-asserted-by":"publisher","first-page":"e77542","DOI":"10.1371\/journal.pone.0077542","volume":"8","author":"MT Graham","year":"2013","unstructured":"Graham MT, Abram CL, Hu Y, Lowell CA . Expression of the TEL-Syk Fusion Protein in Hematopoietic Stem Cells Leads to Rapidly Fatal Myelofibrosis in Mice. PLoS One 2013; 8: e77542.","journal-title":"PLoS One"},{"key":"BFbcj201453_CR40","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.1128\/MCB.24.18.8037-8047.2004","volume":"24","author":"Y Cui","year":"2004","unstructured":"Cui Y, Riedlinger G, Miyoshi K, Tang W, Li C, Deng CX et al. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 2004; 24: 8037\u20138047.","journal-title":"Mol Cell Biol"},{"key":"BFbcj201453_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/emmm.201000062","volume":"2","author":"A Hoelbl","year":"2010","unstructured":"Hoelbl A, Schuster C, Kovacic B, Zhu B, Wickre M, Hoelzl MA et al. Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia. EMBO Mol Med 2010; 2: 98\u2013110.","journal-title":"EMBO Mol Med"},{"key":"BFbcj201453_CR42","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood 1998; 92: 3780\u20133792.","journal-title":"Blood"},{"key":"BFbcj201453_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa .. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 1999; 27: 29\u201334.","journal-title":"Nucleic Acids Res"},{"key":"BFbcj201453_CR44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.V100.1.238","volume":"100","author":"SC Kogan","year":"2002","unstructured":"Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 2002; 100: 238\u2013245.","journal-title":"Blood"},{"key":"BFbcj201453_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng.278","volume":"41","author":"C Lagresle-Peyrou","year":"2009","unstructured":"Lagresle-Peyrou C, Six EM, Picard C, Rieux-Laucat F, Michel V, Ditadi A et al. Human adenylate kinase 2 deficiency causes a profound haematopoietic defect associated with sensorineural deafness. Nat Genet 2009; 41: 106\u2013111.","journal-title":"Nat Genet"},{"key":"BFbcj201453_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2141.2005.05883.x","volume":"132","author":"A Rinaldi","year":"2006","unstructured":"Rinaldi A, Kwee I, Taborelli M, Largo C, Uccella S, Martin V et al. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br J Haematol 2006; 132: 303\u2013316.","journal-title":"Br J Haematol"},{"key":"BFbcj201453_CR47","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.exphem.2003.09.009","volume":"31","author":"BJ Lannutti","year":"2003","unstructured":"Lannutti BJ, Shim MH, Blake N, Reems JA, Drachman JG . Identification and activation of Src family kinases in primary megakaryocytes. Exp Hematol 2003; 31: 1268\u20131274.","journal-title":"Exp Hematol"},{"key":"BFbcj201453_CR48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1182\/blood-2010-03-275990","volume":"116","author":"A Mazharian","year":"2010","unstructured":"Mazharian A, Thomas SG, Dhanjal TS, Buckley CD, Watson SP . Critical role of Src-Syk-PLC{gamma}2 signaling in megakaryocyte migration and thrombopoiesis. Blood 2010; 116: 793\u2013800.","journal-title":"Blood"},{"key":"BFbcj201453_CR49","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ceb.2005.08.010","volume":"17","author":"MH Ginsberg","year":"2005","unstructured":"Ginsberg MH, Partridge A, Shattil SJ . Integrin regulation. Curr Opin Cell Biol 2005; 17: 509\u2013516.","journal-title":"Curr Opin Cell Biol"},{"key":"BFbcj201453_CR50","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1182\/blood-2004-04-1257","volume":"104","author":"SJ Shattil","year":"2004","unstructured":"Shattil SJ, Newman PJ . Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004; 104: 1606\u20131615.","journal-title":"Blood"},{"key":"BFbcj201453_CR51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.tcb.2005.06.005","volume":"15","author":"SJ Shattil","year":"2005","unstructured":"Shattil SJ . Integrins and Src: dynamic duo of adhesion signaling. Trends Cell Biol 2005; 15: 399\u2013403.","journal-title":"Trends Cell Biol"},{"key":"BFbcj201453_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1083\/jcb.200112113","volume":"157","author":"A Obergfell","year":"2002","unstructured":"Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS et al. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. J Cell Biol 2002; 157: 265\u2013275.","journal-title":"J Cell Biol"},{"key":"BFbcj201453_CR53","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-92-6-857","volume":"92","author":"JE Groopman","year":"1980","unstructured":"Groopman JE . The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann Intern Med 1980; 92: 857\u2013858.","journal-title":"Ann Intern Med"},{"key":"BFbcj201453_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2141.1985.tb02956.x","volume":"59","author":"DM McCarthy","year":"1985","unstructured":"McCarthy DM . Annotation. Fibrosis of the bone marrow: content and causes. Br J Haematol 1985; 59: 1\u20137.","journal-title":"Br J Haematol"},{"key":"BFbcj201453_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2141.1994.tb04970.x","volume":"88","author":"MC Martyre","year":"1994","unstructured":"Martyre MC, Romquin N, Le Bousse-Kerdiles MC, Chevillard S, Benyahia B, Dupriez B et al. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. Br J Haematol 1994; 88: 9\u201316.","journal-title":"Br J Haematol"},{"key":"BFbcj201453_CR56","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1182\/blood-2002-04-1133","volume":"100","author":"H Chagraoui","year":"2002","unstructured":"Chagraoui H, Komura E, Tulliez M, Giraudier S, Vainchenker W, Wendling F . Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood 2002; 100: 3495\u20133503.","journal-title":"Blood"},{"key":"BFbcj201453_CR57","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1172\/JCI19540","volume":"113","author":"M Shehata","year":"2004","unstructured":"Shehata M, Schwarzmeier JD, Hilgarth M, Hubmann R, Duechler M, Gisslinger H . TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia. J Clin Invest 2004; 113: 676\u2013685.","journal-title":"J Clin Invest"},{"key":"BFbcj201453_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(02)00398-0","volume":"285","author":"T Kisseleva","year":"2002","unstructured":"Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW . Signaling through the JAK\/STAT pathway, recent advances and future challenges. Gene 2002; 285: 1\u201324.","journal-title":"Gene"},{"key":"BFbcj201453_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gde.2006.12.009","volume":"17","author":"JN Ihle","year":"2007","unstructured":"Ihle JN, Gilliland DG . Jak2: normal function and role in hematopoietic disorders. Curr Opin Genet Dev 2007; 17: 8\u201314.","journal-title":"Curr Opin Genet Dev"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201453","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:52:16Z","timestamp":1672959136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,22]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8]]}},"alternative-id":["BFbcj201453"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2014.53","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,22]]},"assertion":[{"value":"27 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}